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Abstract 
Monocytes/macrophages, which are found in a variety of organs, maintain tissue homeostasis at a steady state and 
act as the first line of defence during pathogen‑induced inflammation in the host. Most monocyte/macrophage line‑
age studies in chickens have been largely performed using cell lines, while few studies using primary cells have been 
conducted. In the present study, the phenotypic and functional characteristics of splenic monocyte/macrophage 
lineage cells during steady state and inflammatory conditions were examined. Splenic monocyte/macrophage line‑
age cells could be identified as  MRC1loMHCIIhi and  MRC1hiMHCIIlo cells based on their surface expression of MRC1 
and MHCII. In the steady state,  MRC1loMHCIIhi cells were more frequently found among  MRC1+ cells.  MRC1loMHCIIhi 
cells expressed a higher number of antigen‑presenting molecules (MHCII, MHCI, and CD80) than  MRC1hiMHCIIlo 
cells. In contrast,  MRC1hiMHCIIlo cells showed better phagocytic and CCR5‑dependent migratory properties than 
 MRC1loMHCIIhi cells. Furthermore,  MRC1hiMHCIIlo cells infiltrated the spleen in vivo and then became  MRC1loMHCIIhi 
cells. During lipopolysaccharide (LPS)‑induced inflammatory conditions that were produced via intraperitoneal (i.p.) 
injection, the proportion and absolute number of  MRC1hiMHCIIlo cells were increased in the spleen. Uniquely, inflam‑
mation induced the downregulation of MHCII expression in  MRC1hiMHCIIlo cells. The major source of inflammatory 
cytokines (IL‑1β, IL‑6, and IL‑12) was  MRC1loMHCIIhi cells. Furthermore,  MRC1hiMHCIIlo cells showed greater bactericidal 
activity than  MRC1loMHCIIhi cells during LPS‑induced inflammation. Collectively, these results suggest that two sub‑
sets of monocyte/macrophage lineage cells exist in the chicken spleen that have functional differences.
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Introduction
Monocytes/macrophages, which comprise the majority 
of mononuclear phagocytes, are derived from bone mar-
row precursors [1]. Macrophages are located in various 
organs and seeded during the prenatal stage, and they 
are maintained through self-proliferation or, to some 
extent, via the infiltration of circulating monocytes [2]. 
Thus, macrophages exist in several types of tissues under 
steady-state conditions, in which they clear apoptotic 
and senescent cells [3, 4]. Furthermore, macrophages are 
rapidly recruited locally via chemokine signals and are 
generated by the differentiation of circulating monocytes 
in response to inflammation or pathogen invasion [5].
Monocytes/macrophages are part of the innate 
immune system and function as the first line of defence 
in the host through various effector functions. They 
express several kinds of pattern recognition receptors 
(PRRs), including Toll-like receptors (TLRs) and C-type 
lectin receptors that recognize pathogens [6], and then 
phagocytose and clear the pathogen by lysosomal acidi-
fication [7]. Once activated, monocytes/macrophages 
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release pro-inflammatory cytokines such as IL-1β, IL-6, 
and IL-12 [8].
Among lymphoid organs, the mammalian spleen is 
known to contain various types of mononuclear phago-
cyte subsets that are defined by phenotype, function and 
localization [9]. However, the spleen of chickens dif-
fers from that of mammals in both structure and func-
tion [10]. It has been reported that red pulp monocyte/
macrophage lineage cells in spleen from chicken express 
MHCII and show a high phagocytosis ability that is simi-
lar to that of mammalian red pulp macrophages [11]. In 
addition, monocyte/macrophage lineage cells are also 
found in chicken ellipsoids [11, 12], which are analogous 
to the mammalian marginal zone.
Chicken mononuclear phagocytes include monocytes, 
and macrophage-like and dendritic cell (DC)-like cells 
[13]. The phenotype and function of macrophage- and 
DC-like cells are poorly defined because of a lack of 
appropriate reagents. However, in vitro culture of mono-
nuclear phagocytes demonstrated that KUL01, which tar-
gets mannose receptor C-type 1 (MRC1), the homologue 
of the mammalian mannose receptor [14], can be used as 
a representative marker of monocyte/macrophage line-
age cells, whereas 8F2 (putative chicken CD11c) can be 
used as a marker of DC-like cells [12]. Furthermore, com-
parative profiling of gene expression in splenic mononu-
clear phagocytes was performed between chickens and 
mammals, demonstrating that  MRC1+ and  CD11c+ cells 
in the spleen in chicken are distinct phagocytic popu-
lations similar to macrophages and DCs, respectively, 
which are the analogous mammalian counterparts [13].
Chicken monocyte/macrophage lineage cells express-
ing MRC1 have been found to exhibit features similar 
to those in mammals, including morphological features 
[15], plasticity [16], and capability for phagocytosis [17, 
18]. Furthermore, they express several TLRs, and the 
activation of TLRs by their ligands induces bacterial lysis 
[19] and pro-inflammatory cytokine secretion [20], sug-
gesting that they induce a similar response during inflam-
mation compared to that of mammals. However, most 
studies of the functional aspects of chicken monocyte/
macrophage lineage cells have been limited to in  vitro 
experiments using cell lines (i.e., HD11 and MQ-NCSU) 
and bone marrow- or monocyte-derived macrophages 
[21–24]. Moreover, few studies have addressed ques-
tions related to defining the function of chicken primary 
monocyte/macrophage lineage cells.
Due to the poorly developed lymphatic system and lack 
of draining lymph nodes in chickens, the spleen is con-
sidered the most important secondary immune organ 
in chickens [25]. Therefore, characterization of splenic 
monocyte/macrophage lineage cells will be helpful to 
investigate the regulation of systemic inflammation in 
chickens. However, how monocyte/macrophage line-
age cells are maintained in the steady state and respond 
to inflammatory conditions in the spleen has not been 
well defined. Therefore, the aim of the present study was 
to examine the phenotype, function, and maintenance of 
splenic monocyte/macrophage lineage cells during steady 
state and inflammatory conditions.
Materials and methods
Experimental animals and their treatment
Fertilized eggs of White Leghorn chickens obtained 
from the University Animal Farm (Pyeongchang cam-
pus, Seoul National University, Korea) were incubated in 
a 37.5–38  °C incubator for 21  days. The hatched chicks 
were housed under conventional conditions and allowed 
free access to food and water until they were 3 weeks old 
without any vaccination. All chickens used were 3 weeks 
of age. All experimental procedures using fertilized eggs 
and chickens were performed with the approval of the 
Institutional Animal Care and Use Committee of Seoul 
National University (IACUC No., SNU-150327-2).
Single‑cell dissociation
The spleen, caecal tonsil, lung, thymus, and bursa of 
Fabricius from 3-week-old chickens were prepared as 
previously mentioned [26, 27] with minor modifica-
tions. Briefly, the organs were minced and washed with 
RPMI-1640 (Thermo Fisher Scientific, Waltham, MA, 
USA) supplemented with 5% heat-inactivated fetal 
bovine serum (FBS; Thermo Fisher Scientific) to obtain 
a single-cell suspension. To isolate the peripheral 
blood mononuclear cells (PBMCs), blood was collected 
through the brachial wing vein using a 5  mL syringe 
equipped with a 26-gauge (0.45  mm diameter) needle 
and stored in BD Vacutainer tubes coated with sodium 
heparin (BD Biosciences, Franklin Lakes, NJ, USA). The 
blood was diluted in phosphate-buffered saline (PBS) 
at a 1:1 ratio, and PBMCs were isolated by density 
gradient centrifugation for 20  min at 400 ×  g without 
braking using Ficoll-Paque (Sigma-Aldrich, St Louis, 
MO, USA) and washed with PBS containing 5% FBS. 
To obtain bone marrow cells, femurs and tibias were 
obtained, both ends of the bone were cut, and the mar-
row was flushed out with RPMI-1640 media supple-
mented with 5% FBS. Clusters within the marrow cell 
suspension were disaggregated using a 70 μm nylon cell 
strainer (Corning Inc., Corning, NY, USA). Red blood 
cells in the cell suspension were lysed using ACK buffer 
(Corning Inc.) for 5–7 min at 4  °C and then washed. 
A single cell suspension was passed through a 70  μm 
cell strainer. The total cell numbers were determined 
using an automatic cell counter. The absolute number 
of cells in the target cell population was calculated by 
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multiplying the percentage of target cells (Additional 
file 1A) by the total cell number for each organ exam-
ined [26, 28].
Flow cytometric analysis
For cell surface staining, 0.5−1 × 106 cells (splenocytes 
or sorted cells) were stained with fluorochrome-con-
jugated monoclonal antibodies in PBS containing 5% 
FBS for 20 min at 4  °C in the dark. The primary anti-
bodies used were anti-chicken MHCII-FITC (2G11), 
MRC1-PE (KUL01), CD3-Pacific Blue (CT3), Bu-1-Al-
exa-647 (AV20), MHCI-Biotin (F21-2) (all from South-
ern Biotechnology, Birmingham, AL, USA), and CD80 
(IAH:F864:DC7) (BioRad Laboratories, Hercules, CA, 
USA). After incubation for 20 min, the cells were washed 
with PBS containing 5% FBS. For secondary antibody 
staining, the cells were stained with streptavidin APC/
Cy7, PE/Cy7 anti-mouse IgG1, or APC anti-mouse IgG2a 
(all from BioLegend, San Diego, CA, USA). Cell death 
was assessed by annexin V (Corning Inc.) and propidium 
iodide (PI; Sigma-Aldrich) staining. All samples were 
analysed on a FACS Canto II (BD Biosciences). The pro-
portion and number of cells relative to the total cell num-
ber were analysed using FlowJo software (Tree Star Inc., 
Ashland, OR, USA).
RNA extraction and cDNA synthesis
Total RNA was extracted from the total splenocytes, 
magnetic bead-sorted splenic  MRC1+ cells or FACS-
sorted  MRC1hiMHCIIlo and  MRC1loMHCIIhi cells by 
using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) 
according to the manufacturer’s instructions or an RNe-
asy kit (Qiagen, Hilden, Germany). Briefly, the cells 
(5 × 105 cells for FACS-sorted cells and 5 × 106 cells for 
splenocytes) were treated with 1 mL of TRIzol. Total 
RNA was isolated by the addition of 200 µL of chloroform 
followed by centrifugation at 12  000 × g for 15  min at 
4 °C. The aqueous phase was transferred into a new tube, 
and 500 µL of isopropanol was added. Then, the samples 
were incubated for 10 min at room temperature for RNA 
precipitation and centrifuged at 12 000 × g for 10 min at 
4  °C. The RNA pellet was obtained after washing with 
75% ethanol, air drying for 5–10 min, and resuspension 
in diethyl pyrocarbonate (DEPC)-treated water. The 
RNA concentration was quantified using a NanoDrop 
(Amersham Biosciences, Piscataway, NJ, USA) at 260 nm. 
Subsequently, 500 ng of purified RNA was reverse-tran-
scribed into cDNA using M-MLV Reverse Transcriptase 
(Invitrogen) according to the manufacturer’s instructions.
Quantitative real‑time PCR
Quantitative real-time PCR was performed with cDNA 
using a StepOne Plus real-time PCR system (Applied 
Biosystems, Foster City, CA, USA).  SYBR® Green PCR 
Master Mix (Applied Biosystems) was used according 
to the manufacturer’s specifications. The PCR was car-
ried out in a 96-well reaction plate with 10 μL of  SYBR® 
Green PCR Master Mix, 0.5 μL of each of the primers, 
and 9 μL of cDNA template mixed with DEPC-treated 
water. Each reaction involved a preincubation at 95 °C for 
10 min, followed by 30 thermal cycles at 95  °C for 15  s, 
55 °C for 30 s, and 72 °C for 30 s. The relative quantifica-
tion of the target genes was calculated using the  2−ΔΔCt 
method. Target gene expression was normalized to the 
β-actin mRNA level. Primers were designed using NCBI 
Primer-BLAST as shown in Table  1 and synthesized by 
Bioneer Inc. (Daejeon, Korea).
Cell sorting
Splenocytes from 3-week-old chickens were stained with 
mouse anti-chicken MRC1 antibody (clone KUL01) for 
20 min at 4 °C. After washing with isolation buffer (PBS 
containing 0.5% BSA and 2  mM EDTA), the cells were 
incubated with anti-mouse IgG1 microbeads (Milte-
nyi Biotec, Bergisch Gladbach, Germany) in isolation 
buffer for 20 min at 4 °C in the dark. Then, the cells were 
washed, suspended in isolation buffer, and separated on 
an LS column in the magnetic field of the MACS Separa-
tor (Miltenyi Biotec; > 95% purity).  MRC1hiMHCIIlo and 
Table 1 Primer sequences used for RT-qPCR 
*F: Forward primer for PCR, #R: Reverse primer for PCR.
Target gene Primer sequence (5′–3′) Accession no.
CCR5 F*‑GTG GTC AAC TGC AAA AAG CA
R#‑GCC CGT TCA ACT GTG TCG 
NM_001045 834.1
CCR2 F‑ATG CCA ACA ACA ACG TTT GA
R‑TGT TGC CTA TGA AGC CAA A
NM_001045835.1
CX3CR1 F‑TCC AGA ACG ATC AAG CAC AG
R‑CGG TGT TCA GTT CCA CAT TG
XM_418820.2 
IL‑10 F‑CGC TGT CAC CGC TTC TTC A
R‑CGT CTC CTT GAT CTG CTT GATG 
NM_001004414.2
TGF‑β F‑GAG TCC GAG TAC TAC GCC AAAGA 
R‑CAC GTT AAA GCG GAA CAC ATTG 
NM_205454.1
COX‑2 F‑TGC TGG CCG CTC TCCTT 
R‑GTC CTC GTG CAG TCA CAT TCA 
NM_001167719.1
IL‑1β F‑ACC CGC TTC ATC TTC TAC CG
R‑TCA GCG CCC ACT TAG CTT G
NM_204524.1
IL‑12p40 F‑CCT GTG GCT CGC ACT GAT AA
R‑TCT TCG GCA AAT GGA CAG TA
NM_213571.1
IL‑6 F‑CGA GTG GGT GCT GTG TCA AA
R‑CAT CCC TGA ACG TGT ATT TA
XM_015281283.2
iNOS F‑AGC AGC TGA GTG ATG ATC CA
R‑GGA CCG AGC TGT TGT AGA GA
NM_204961.1
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 MRC1loMHCIIhi cells were sorted with a 70 μm nozzle by 
using a FACS ARIA III (BD Biosciences) after magnetic 
bead sorting. The purity of the two subsets was > 99%.
Phagocytosis assay
For the determination of dead cell uptake, splenocytes 
from 3-week-old chickens were labelled with CellTrace™ 
Violet (CTV; Thermo Fisher Scientific) for 10  min and 
boiled at 56  °C for 30  min to generate dead cells. Cell 
death was confirmed by annexin V and PI staining. Mag-
netic bead-sorted splenic  MRC1+ cells (1 × 106 cell/mL) 
were cultured in 24-well plates (Thermo Fisher Scientific) 
with RPMI-1640 supplemented with 10% FBS and 1% 
penicillin/streptomycin (Invitrogen) at 39 °C in a 5%  CO2 
incubator for 3 h. Then, the dead cells were coincubated 
with bead-sorted splenic  MRC1+ cells at a 1:1 ratio for 
an additional 1 h at either 39 °C or 4 °C. For the determi-
nation of ovalbumin (OVA) uptake, bead-sorted  MRC1+ 
cells (1 × 106 cell/mL) were cultured for 3 h in a 24-well 
plate (Thermo Fisher Scientific) followed by 1 h of incu-
bation with OVA-FITC (1–2 μg/mL) at 39 °C or 4 °C. The 
floating cells and trypsinized adherent cells were col-
lected and washed twice with PBS supplemented with 5% 
FBS. After staining with anti-chicken MHCII and MRC1, 
the proportion or intensity of  CTV+ or OVA-FITC+ cells 
in the  MRC1+ subsets was examined by using a FACS 
Canto II. The uptake capability was calculated from the 
data obtained at 39 °C, which was normalized according 
to data obtained at 4 °C.
In vitro migration assay
Migration ability was measured by using a modified 
Boyden chamber (Corning Costar, Pittsburgh, PA, USA) 
containing a polycarbonate membrane filter (6.5-mm 
diameter in a 24-well plate with a 5-μm pore size). The 
inserts were preincubated with media (RPMI-1640 con-
taining 5% FBS) for 1  h. Magnetic bead-sorted splenic 
 MRC1+ cells (1 × 106) were placed in the upper chamber 
with 200 μL of media, and the lower chamber contained 
500 μL media alone or media containing recombinant 
chicken CCL5 (Kingfisher Biotechnology, Saint Paul, 
MN, USA). The plates were incubated at 39 °C in 5%  CO2 
for 3 h. The cells that had migrated to the lower cham-
ber were collected, and the cells that remained attached 
to the insert were recovered by placing the bottom of the 
insert into 500 μL PBS containing 0.05% (w/v) trypsin–
EDTA and tapping it lightly. The migration index was cal-
culated as follows: migration index = [(cell number in the 
lower chamber with chemokines) − (cell number in the 
lower chamber without chemokines)]/(number of cells 
initially added).
Adoptive transfer assay
To label the injected donor cells, the total PBMCs 
(1 × 107) and sorted splenic  MRC1loMHCIIhi cells 
(5 × 106), isolated from 3-week-old chickens were stained 
with CTV (Thermo Fisher Scientific) for 10 min at 39 °C 
in an incubator with 5%  CO2. The cells were washed 
with PBS supplemented with 5% FBS and centrifuged at 
300–400 × g for 3 min at 4 °C. The cells were resuspended 
in PBS and injected into the 3-week-old recipient chick-
ens through the wing vein. At the same time, to induce 
systemic inflammation, the chickens were injected with 
LPS (Escherichia coli serotype O111:B4; Sigma-Aldrich) 
through the intraperitoneal route at a dosage of 1  mg/
kg body weight. The control animals received the same 
amount of PBS.
Gentamicin protection assay
Phagocytosis and bactericidal activity were examined 
by a gentamicin protection assay (Additional file 7) [29]. 
E. coli K99 cells were cultured in LB media at 37  °C for 
4 h. To prepare the bacterial suspensions, the calculated 
number  (OD600 = 1) of E. coli K99 cells was centrifuged at 
300–400 × g for 3 min at 4 °C and resuspended in 6.6 mL 
RPMI-1640 supplemented with 5% FBS.  MRC1hiMHCIIlo 
and  MRC1loMHCIIhi cells (5 × 105 cells/mL) were sorted 
using a FACS Aria II and incubated at 39  °C in 24-well 
plates for 3  h. Then, the bacterial suspensions were 
cocultured with the preincubated  MRC1+ cell subsets at 
a multiplicity of infection (MOI) of 20:1 at 39  °C. After 
1 h, the cells were washed twice with 1 mL of RPMI-1640 
supplemented with 5% FBS, which was replaced with 
RPMI-1640 containing 200  µg/mL gentamicin (Thermo 
Fisher Scientific) to kill the remaining extracellular bac-
teria by incubation for 10 or 60 min. The cells were then 
washed twice and resuspended in 1  mL of 0.1% Triton 
X-100 (Sigma-Aldrich) in PBS. To determine the num-
ber of colony forming units (CFUs), 100 μL of each seri-
ally diluted sample was plated on Tryptic Soy Agar (TSA) 
(BD Biosciences) followed by overnight incubation at 
37 °C.
Genotyping
Blood samples were collected from randomly chosen 
White Leghorn chickens. Genomic DNA (gDNA) was 
extracted from blood by using the  AccuPrep® Genomic 
DNA Extraction Kit (Bioneer Inc.) according to the 
manufacturer’s instructions. PCRs were performed using 
10 ng of genomic DNA, 5 pmol each of the forward and 
reverse primers, 2 μL of buffer (10x), 2 mM of  MgCl2, 1 
μL of 10 mM dNTPs, 0.25 unit of Taq DNA polymerase 
(all from Bioneer Inc.) and water in a final volume of 20 
μL. The PCR was performed at 94 °C for 5 min, followed 
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by 35 cycles of 94 °C for 30 s, 65 °C for 30 s, and 72 °C for 
30 s and a final extension at 72  °C for 5 min. The prim-
ers were LEI0258-F: 5′-CAC GCA GCA GAA CTT GGT 
AAGG-3′ and LEI0258-R: 5′-AGC TGT GCTC AGT CCT 
CAG TGC -3′ [30, 31]. BF2 sequence-based typing (SBT) 
was performed by sequencing each product obtained 
from the exon 2 region of the chicken BF2 gene using 
the forward primer 5′-GCA GAG CTC CAT ACC CTG 
CGGTA-3′ and the reverse primer 5′-GCC GGT CTG 
GTT GTA GCG CCG-3′ [32, 33]. All primers were synthe-
sized by Bioneer Inc. PCR products were electrophoresed 
on a 1.5% agarose gel with 0.5 X TBE buffer. The PCR 
products were subjected to Sanger sequencing with the 
forward and reverse primers used for PCR. We retrieved 
the nucleotide sequence of exon 2 of the chicken MHC 
class I BF2 gene by using the Ensembl genome browser 
[34]. Sequence analyses were performed with CLUSTAL 
Omega [35] and Blast [36].
Statistical analysis
Statistical analysis (one-way ANOVA with the Tukey 
post-test or two-way ANOVA with the Bonferroni post-
test) was performed using GraphPad Prism (version 
7.03, GraphPad Software, San Diego, USA). Differences 
were considered significant if *P < 0.05, ** P < 0.01, or 
***P < 0.001.
Results
Two subsets of splenic  MRC1+ cells showed different 
expression patterns for MHCII and MRC1
To investigate the distribution of chicken primary mono-
cyte/macrophage lineage cells in different organs, pri-
mary (bone marrow, thymus, and bursa of Fabricius) 
and secondary (spleen, caecal tonsil, and lung) immune 
organs from 3-week-old chickens were collected, and 
their phenotypes were analysed based on the expression 
of MRC1, a well-known chicken monocyte/macrophage 
marker (clone: KUL01) [11], and MHCII (Additional 
file 1). All organs, except for the spleen, showed compara-
ble MRC1 and MHCII levels with homogeneous or indis-
tinguishable expression (Figure 1A). Interestingly, splenic 
 MRC1+ cells only showed two distinct populations with 
heterogeneous expression of MHCII and MRC1. Based 
on the expression patterns of MRC1 and MHCII, the 
two populations were designated  MRC1loMHCIIhi and 
 MRC1hiMHCIIlo (Figure  1B). In the spleen, the propor-
tion and absolute number of  MRC1loMHCIIhi cells were 
higher than those of  MRC1hiMHCIIlo cells at the steady 
state (Figures  1C and D).  MRC1loMHCIIhi cells exclu-
sively outnumbered  MRC1hiMHCIIlo cells during the first 
3 weeks of life (Additional file 2).
To characterize the phenotypic features of the 
two  MRC1+ subsets, cells were stained with several 
Figure 1 Two distinct populations of MRC1+ cells were found 
in spleen from chickens based on the expression of MRC1 and 
MHCII. Various organs were harvested from 3‑week‑old chickens. 
Single cells were stained with anti‑chicken MRC1 and MHCII 
antibodies and analysed by flow cytometry. The gating strategy is 
shown in Additional file 1. A Representative dot plots of  MRC1+ cells 
in bone marrow, the bursa of Fabricius, thymus, blood, caecal tonsil, 
and lung (n = 10). An identical gating strategy for  MRC1loMHCIIhi 
and  MRC1hiMHCIIlo cells in the spleen was used in each panel. A 
representative figure from three independent experiments with 
similar results is shown. B Two distinct populations of spleicn  MRC1+ 
cells are shown. The gate with the solid line represents  MRC1loMHCIIhi 
cells, and the gate with the dashed line represents  MRC1hiMHCIIlo 
cells. C Proportion and D absolute number of  MRC1loMHCIIhi and 
 MRC1hiMHCIIlo cells in the spleen. E Single cells prepared from 
the spleen were stained with anti‑chicken MRC1, MHCII, MHCI, and 
CD80 antibodies. Representative histograms display the surface 
expression of MRC1, MHCI, MHCII or CD80 on  MRC1loMHCIIhi and 
 MRC1hiMHCIIlo cell (upper panel). Dashed histograms represent the 
isotype control. The bar graph represents the mean fluorescence 
intensity (MFI) of the target molecules (lower panel). Representative 
histograms are shown with data from three independent 
experiments with similar results. Data are represented as the 
mean ± SD. ***P < 0.001.
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antibodies targeting cell surface markers involved in 
antigen presentation. The expression of MHCII, MHCI, 
and CD80 was higher in  MRC1loMHCIIhi cells than 
in  MRC1hiMHCIIlo cells (Figure  1E), suggesting that 
 MRC1loMHCIIhi cells have better antigen presentation 
potential than  MRC1hiMHCIIlo cells.
Taken together, these results suggest that, unlike other 
organs, chicken spleen possesses unique  MRC1+ popula-
tions based on the distinct expression patterns of MRC1 
and MHCII.
Splenic  MRC1hiMHCIIlo cells exhibited greater phagocytic 
ability than splenic  MRC1loMHCIIhi cells during steady state 
conditions
Phagocytosis of pathogens and aberrant cells is an impor-
tant task of antigen-presenting cells for the activation 
of the immune system and the maintenance of homeo-
stasis [1]. To examine the phagocytic activity of  MRC1+ 
cells, CTV-labelled dead cells and OVA-FITC were incu-
bated with bead-sorted  MRC1+ cells. A higher number 
of  CTV+ cells was detected among  MRC1hiMHCIIlo cells 
than among  MRC1loMHCIIhi cells (Figure 2A and Addi-
tional file  3A), indicating the increased uptake of dead 
cells. Similarly, OVA uptake was also much higher in 
 MRC1hiMHCIIlo cells than in  MRC1loMHCIIhi cells (Fig-
ure 2B and Additional file 3B). These results suggest that 
 MRC1hiMHCIIlo cells have superior phagocytosis prop-
erties compared to those of  MRC1loMHCIIhi cells.
Splenic  MRC1hiMHCIIlo cells showed higher migration 
capacity than splenic  MRC1loMHCIIhi cells
Monocytes/macrophages possess migration capacity, 
which is important in regulating infection and inflam-
mation [5, 37] and in maintaining organ homeostasis, 
even in the steady state [38, 39]. To evaluate the migra-
tion capacity, the two subsets were examined for their 
transcriptional expression of chemokine receptors. The 
transcription level of CCR5 was significantly upregu-
lated in  MRC1hiMHCIIlo cells compared to that in 
 MRC1loMHCIIhi cells (Figure 3A). However, comparable 
expression levels of CCR2 and  CX3CR1 were found in 
both  MRC1+ subsets (Figures 3B and C). Next, a migra-
tion assay was performed on bead-sorted  MRC1+ cells 
using recombinant chicken CCL5, a ligand of CCR5. As 
shown in Figure 1C, splenic  MRC1+ cells contained a high 
proportion of  MRC1loMHCIIhi cells (approximately 70%) 
and a low proportion of  MRC1hiMHCIIlo cells (approxi-
mately 30%). After migration in the absence of CCL5 
(i.e., spontaneous migration),  MRC1loMHCIIhi cells 
were detected at high levels in the bottom well. How-
ever, a high percentage and number of  MRC1hiMHCIIlo 
cells were observed (Figures 3D and E) when CCL5 was 
added, which is consistent with high CCR5 expression 
on  MRC1hiMHCIIlo cells. We confirmed that 3 h of cul-
ture with or without CCL5 did not induce the alteration 
of MHCII and MRC1 expression in the migration assay 
(data not shown). Taken together, the results indicated 
that  MRC1hiMHCIIlo cells showed a CCR5-dependent 
migratory pattern.
Inflammation caused an increase in both the proportion 
and absolute number of splenic  MRC1hiMHCIIlo cells
Next, to further characterize splenic  MRC1+ cells under 
inflammatory conditions in  vivo, chickens were treated 
with LPS through the intraperitoneal route. No obvious 
differences were found in the composition of immune 
cells, including  MRC1+ cells, B cells, and T cells, in the 
spleen at 4 h after stimulation (Additional file 4). While 
two  MRC1+ subpopulations were detected, their propor-
tion and absolute number were greatly altered in spleens 
from LPS-treated chickens (Figure 4A).  MRC1loMHCIIhi 
cells were the major population (over 65%) among splenic 
 MRC1+ cells in the PBS-treated control group, which 
was similar to that found in the spleen in the steady state 
(Figure  1B). However, at 4  h post-LPS stimulation, the 
proportion and absolute number of  MRC1hiMHCIIlo cells 
were greatly increased, resulting in a reversal of the ratio 
of the two populations (Figures  4B, C). Collectively, the 
results showed that LPS-induced inflammation caused 
a change in the proportion and absolute number of the 
subsets of  MRC1+ cells.
Figure 2 Splenic MRC1hiMHCIIlo cells exhibit phagocytic 
properties superior to those of MRC1loMHCIIhi cells under 
steady‑state conditions. For the in vitro phagocytosis assay,  MRC1+ 
cells were sorted from splenocytes by positive selection.  MRC1+ cells 
(1 × 106 cells/mL) were preincubated for 3 h and then incubated with 
A CTV‑labelled dead cells (1 × 106 cells/mL) or B OVA‑FITC (1 ng/mL) 
for 1 h at 39 °C or 4 °C. The gating strategy is shown in Additional 
file 3. Data obtained at 39 °C were normalized according to results 
obtained at 4 °C. The data represent A the percentages of the  MRC1+ 
cell subsets in the  CTV+ gate and B the mean fluorescence intensity 
(MFI) of OVA‑FITC in  MRC1loMHCIIhi and  MRC1hiMHCIIlo cells (n = 10). 
Data are represented as the mean values ± SD. ***P < 0.001.
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Inflammation triggered phenotypic changes in splenic 
 MRC1+ cells
In mammals, LPS can trigger phenotypic changes by acti-
vating mononuclear phagocytes both in vivo and in vitro 
[40]. Chicken macrophage cell lines treated with LPS 
showed a similar response [41]. In the present study, the 
phenotypes of the two splenic  MRC1+ subpopulations 
were analysed in chickens that had been administered 
with  LPS via the intraperitoneal route. The expression 
level of MRC1 was further decreased in  MRC1loMHCIIhi 
cells but not in  MRC1hiMHCIIlo cells (Figure 5A). How-
ever, granularity (indicated by side scatter, SSC) was 
greatly increased in  MRC1hiMHCIIlo cells showing a 
reduction in MHCII expression at 4 h after LPS adminis-
tration (Figures 5B and C).
A few factors have been known to reduce the expres-
sion of MHCII, including TGF-β [42], IL-10 [43], and 
COX-2 [44, 45]. To elucidate the potential mediators 
that negatively regulate MHCII expression in the spleen 
during inflammation, the transcription levels of TGF-β, 
IL-10, and COX-2 in total splenocytes during inflamma-
tion were analysed by RT-qPCR. The mRNA expression 
levels of IL-10 and TGF-β were similar between the PBS 
and LPS groups (Figures  5D and E). Interestingly, how-
ever, the level of COX-2 was greatly elevated in the LPS 
group compared to that in the PBS group (Figure  5F), 
suggesting that COX-2 might be a potential mediator 
responsible for the downregulation of MHCII expression.
Two subsets of splenic  MRC1+ cells showed distinct 
phenotypic changes during LPS‑induced inflammation
In mammals, tissue resident macrophages are seeded 
in the prenatal stage and maintain their population by 
self-renewal [46] and/or are  replenished  by the infiltra-
tion of monocytes [38, 47]. To elucidate whether the 
two subsets of splenic  MRC1+ cells were replenished by 
circulating monocytes, we performed cell transfer using 
blood or splenic cells from chickens that maintained 
conserved haplotypes in the MHC region (Additional 
file  5). PBMCs were isolated from blood, labelled with 
Figure 3 Splenic MRC1hiMHCIIlo cells migrated towards CCL5 better than MRC1loMHCIIhi cells. A‑C Chicken splenocytes were sorted into 
 MRC1loMHCIIhi and  MRC1hiMHCIIlo cell populations using a cell sorter. The transcriptional levels of the chicken chemokine receptors A CCR5, B 
CCR2 and C  CX3CR1 were analysed by RT‑qPCR. Their expression was normalized to the β‑actin mRNA level (n = 10). Data are represented as the 
mean values ± SD. ***P < 0.001. D, E For the in vitro migration assay, bead‑sorted splenic  MRC1+ cells (1 × 106 cells/mL) in 200 μL of media were 
placed in the insert of the transwell plate. The lower compartment was filled with media in the absence or presence of recombinant chicken 
CCL5 protein (50 ng/mL). After 1 h, D the percentage and E absolute number of migrated cells in the lower compartment were quantified by flow 
cytometry (n = 10). Data are represented as the mean values ± SD. **P < 0.01 ***P < 0.001.
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CTV, and transferred into recipient chickens. Then, the 
kinetic changes in the two splenic  MRC1+ subsets were 
analysed in CTV-positive cells from recipient animals. 
Circulating  MRC1+ cells from PBMCs exhibited the 
homogenous expression of MRC1 and MHCII in both 
control and LPS-treated chickens (Additional file  6). At 
1 h post-transfer, most CTV-positive cells were detected 
in the  MRC1hiMHCIIlo population (Figures  6A and G), 
indicating that  MRC1hiMHCIIlo cells represent newly 
infiltrated cells from blood. However, CTV-positive cells 
were found and gradually increased in number within the 
 MRC1loMHCIIhi population at 6 and 48 h after cell trans-
fer (Figures 6B, C and G). Collectively, the results showed 
that the two splenic  MRC1+ subsets were replenished by 
monocytes and  MRC1loMHCIIhi cells were derived from 
 MRC1hiMHCIIlo cells.
To examine how  MRC1hiMHCIIlo cells were increased 
during LPS-induced inflammation (Figures  4B and C), 
we hypothesized two possibilities: i) a delay in the trans-
formation of  MRC1hiMHCIIlo cells into  MRC1loMHCIIhi 
cells and ii) phenotype change of  MRC1loMHCIIhi cells 
into  MRC1hiMHCIIlo cells.
Thus, CTV-labelled PBMCs were adoptively trans-
ferred via the wing vein in age-matched recipients, and 
LPS injection was performed through the intraperito-
neal route at the same time. At 1 h post-adoptive trans-
fer, CTV-labelled cells were readily observed within the 
 MRC1hiMHCIIlo population in the LPS-treated groups 
(Figures 6D and G), similar to that observed in the con-
trol (Figures  6A and G). However, at 6  h post-adoptive 
transfer, CTV-positive cells were still observed at high 
numbers within the  MRC1hiMHCIIlo population in 
Figure 4 LPS‑induced inflammation in chickens resulted in changes in the proportion and number of the two populations of splenic 
MRC1+ cells. Chickens were administered PBS or LPS (1 mg/kg body weight) i.p. After 4 h, the spleens were collected, and the splenocytes were 
analysed to determine the number and proportional changes of the subtypes of  MRC1+ cells by flow cytometry. A Representative dot plot with 
similar results showing  MRC1+ cells from the spleen of chickens administered PBS or LPS. The solid line represents  MRC1loMHCIIhi cells, whereas the 
dashed line represents  MRC1hiMHCIIlo cells. The bar graph represents the B proportion and C absolute number of the two subsets in the PBS or LPS 
administration group (n = 10). Data are represented as the mean values ± SD. **P < 0.01, ***P < 0.001.
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Figure 5 LPS‑induced inflammation in chickens decreased MHCII expression in splenic MRC1hiMHCIIlo cells. Chickens were administered 
PBS or LPS (500 μL of 1 mg/kg body weight) i.p. for 4 h. Then, the spleen was collected and analysed to determine the A‑C phenotype and D‑F 
mRNA levels of potential mediators through flow cytometry and RT‑qPCR, respectively. Representative histograms show the changes in A MRC1, B 
SSC, and C MHCII expression in the two subsets at 4 h after LPS injection. Solid histograms represent the PBS group, and dashed histograms show 
the LPS group. Dashed histograms without colour (left) and with colour (right) represent the isotype control. The bar graph represents the MFI of 
the expression (n = 10) **P < 0.01, ***P < 0.001. Transcriptional levels of D IL‑10, E TGF‑β, and F COX‑2 in splenocytes were examined by RT‑qPCR. The 
expression was normalized to the β‑actin mRNA level (n = 10). Data are represented as the mean values ± SD. **P < 0.01.
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Figure 6 Splenic MRC1+ cells were replenished by monocytes and showed distinct phenotypic changes in chickens with LPS‑induced 
inflammation. A–G PBMCs were isolated from 3‑week‑old chickens, labelled with CTV, and transferred into age‑matched recipient chickens via the 
intravenous route (200 μL of 1 × 107 cells). To cause LPS‑induced inflammation, recipient chickens were intraperitoneally administered 200 μL of LPS 
(1 mg/kg body weight) or the same volume of PBS (control) immediately after the cell transfer. At 1, 6, and 48 h after LPS administration, spleens 
were isolated from recipient chickens, and the splenocytes were stained with anti‑chicken MRC1 and MHCII antibodies. Injected PBMCs were 
distinguished from recipient cells (grey dots) by analysing the  CTV+‑pre‑gated cells (pink dots). In addition, the  MRC1+ cells were gated, and the 
expression of MRC1 and MHCII was examined by flow cytometry for  MRC1loMHCIIhi (solid line) and  MRC1hiMHCIIlo cells (dashed line). Representative 
dot plot of the results from 1‑, 6‑, and 48‑h post‑adoptive transfer A–F showed the proportion of donor  MRC1+ cells (pink) within the recipient 
 MRC1+ populations (grey) in the spleen. The bar graph G represents the proportion of  MRC1loMHCIIhi and  MRC1hiMHCIIlo cells within  CTV+MRC1+ 
donor cells in the recipient after adoptive transfer (n = 10). H  MRC1loMHCIIhi cells were sorted from the spleen of 3‑week‑old chickens and labelled 
with CTV. CTV‑labelled  MRC1loMHCIIhi cells were transferred into age‑matched recipient chickens via the intravenous route (200 μL of 1 × 107 cells). 
Then, the recipient chickens were intraperitoneally administered 200 μL of LPS (1 mg/kg body weight). Pink dots represent donor cells, and grey 
dots recipient cells. The bar graph displays the proportions of  MRC1loMHCIIhi and  MRC1hiMHCIIlo cells within  CTV+MRC1+ cells (pink in the left 
panel) at 6 h after the cell transfer (n = 6). Data are represented as the mean values ± SD. * P < 0.05, *** P < 0.001.
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the LPS-treated group (Figures  6E and G) compared to 
that in the PBS control (Figures  6B and G), indicating 
that LPS-induced inflammation delayed the appearance 
of donor cells in the  MRC1loMHCIIhi cell population 
gate. Notably, in the LPS-treated group at 48  h post-
adoptive transfer, most  CTV+ cells were found within 
the  MRC1loMHCIIhi cell population (Figures 6F and G), 
which was similar to that observed in the PBS group at 
48 h post-adoptive transfer (Figures 6C and G).
Another possible explanation for the increase in 
 MRC1hiMHCIIlo cells during LPS-induced inflamma-
tion could be the phenotypic change of  MRC1loMHCIIhi 
cells into  MRC1hiMHCIIlo cells. To investigate whether 
 MRC1loMHCIIhi cells changed their phenotype dur-
ing inflammation, CTV-labelled  MRC1loMHCIIhi cells 
were adoptively transferred via the wing vein, and i.p. 
LPS injection was performed at the same time. At 6 h 
post-adoptive transfer, almost all CTV-positive cells 
were found within the  MRC1loMHCIIhi gate (Fig-
ure  6H), suggesting that  MRC1loMHCIIhi cells did not 
change their phenotype in LPS-induced inflamma-
tion conditions. Collectively, the results indicated that 
the increase in  MRC1hiMHCIIlo cells during inflam-
mation was caused by a delay in the transformation of 
 MRC1hiMHCIIlo cells into  MRC1loMHCIIhi cells.
Splenic  MRC1loMHCIIhi cells were more likely to show 
cytokine expression compared to splenic  MRC1hiMHCIIlo 
cells
Monocytes/macrophages are the major source of inflam-
matory mediators during inflammation [8]. To investigate 
their ability to produce inflammatory mediators, the two 
splenic cell subsets were sorted from spleen after LPS 
administration, and the mRNA expression of IL-1β, IL-6, 
IL-12p40, and iNOS were examined. The transcription 
levels of pro-inflammatory cytokines, such as IL-1β, IL-6 
and IL-12p40, were higher in  MRC1loMHCIIhi cells than 
in  MRC1hiMHCIIlo cells at both 2 and 4 h post-LPS injec-
tion (Figures 7A–C). No significant difference was found 
in iNOS mRNA expression at 4  h post-LPS injection, 
although iNOS mRNA expression in  MRC1hiMHCIIlo 
cells was higher than that in  MRC1loMHCIIhi cells 
at 2  h post-LPS injection (Figure  7D). Together, the 
results showed that  MRC1loMHCIIhi cells have a greater 
capability to express inflammatory cytokines than 
 MRC1hiMHCIIlo cells.
Splenic  MRC1hiMHCIIlo cells showed greater 
bactericidal activity than splenic  MRC1loMHCIIhi cells 
during LPS‑induced inflammation
The results showed that LPS-induced inflamma-
tion increased the proportion and absolute number 
of  MRC1hiMHCIIlo cells (Figures  4B and C), while the 
main source of inflammatory cytokines during inflam-
mation was  MRC1loMHCIIhi cells. Interestingly, how-
ever, granularity, as indicated by SSC (Figure  5B) and 
the mRNA expression of iNOS (Figure  7D), were sig-
nificantly increased in  MRC1hiMHCIIlo cells after LPS 
administration. Therefore, a gentamicin protection assay 
was conducted to evaluate the bactericidal activity of the 
cells (Additional file  7). Since the uptake capability of 
the two subsets was different in steady state conditions 
(Figures 2B and C), gentamicin was added to the cells 10 
or 60  min prior to the test of bacterial uptake or clear-
ance, respectively. The results showed similar rates of 
bacterial clearance in both cell lysates; however, bacte-
rial uptake was higher in  MRC1hiMHCIIlo cells than in 
 MRC1loMHCIIhi cells (Figure  8A). Thus, similar to that 
observed in steady-state conditions,  MRC1hiMHCIIlo 
cells are more likely to exhibit bacterial uptake compared 
to  MRC1loMHCIIhi cells during LPS-induced inflam-
mation. Interestingly, however,  MRC1hiMHCIIlo cells 
have greater bactericidal activity than  MRC1loMHCIIhi 
cells (Figure  8B). Taken together, the results indicated 
that the increase in  MRC1hiMHCIIlo cells during LPS-
induced inflammation is more likely to be responsible for 
the increase in bactericidal activity than the increase in 
 MRC1loMHCIIhi cells.
Discussion
In chickens, very few studies have been conducted on the 
function of primary mononuclear phagocytes.  CD11c+ 
and  MRC1+ cells have been reported to be analogous 
to mammalian DCs and monocyte/macrophage line-
age cells, respectively [13]. Although the presence of 
these two subpopulations has also been reported among 
splenic  MRC1+ cells, the functional characteristics of 
splenic  MRC1+ cells have not been fully elucidated. 
Therefore, in the present study, splenic  MRC1+ subpop-
ulations were characterized into two subsets based on 
their surface expression of MHCII and MRC1 and were 
examined for their phenotype, function, and response to 
inflammatory stimulation (Table 2).
Phagocytosis of dead cells and pathogens is one of the 
most important functional features of tissue resident 
macrophages in maintaining the homeostasis of tissues 
and organs [3]. In the present study,  MRC1hiMHCIIlo cells 
showed higher phagocytic activity than  MRC1loMHCIIhi 
cells. The exact mechanism involved in the phagocyto-
sis of apoptotic cells and pathogens has yet to be fully 
elucidated. Several receptors, such as T cell membrane 
protein 4 (TIM4) [48], receptor tyrosine kinase Mer 
(MerTK) [49], and mannose receptor [50], are known for 
their important role in the recognition and phagocytosis 
of apoptotic cells and pathogens in mice. Similarly, the 
role of TIM4 in phagocytosing apoptotic cells has been 
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reported in chickens [18]. Therefore, the higher phago-
cytic activity of  MRC1hiMHCIIlo cells compared to that 
of  MRC1loMHCIIhi cells is likely linked to the expression 
level of MRC1, a chicken mannose receptor [14].
Macrophages are functionally classified as M1 and M2 
types in mice and humans [51, 52]. M1 macrophages 
express the well-known signature markers iNOS and 
CD80 and show the upregulation of MHCII, and they 
exhibit pro-inflammatory responses that often function 
to clear invading pathogens. M2 macrophages, which 
express CD206 and PPAR-γ as signature markers, play a 
role in immunoregulation and tissue repair, including the 
phagocytosis of dead cells. However, the exact definition 
and functional relevance of M1 and M2 macrophages in 
chickens has not been established. In the present study, 
 MRC1hiMHCIIlo cells phagocytosed dead cells better 
and expressed higher levels of MRC1, which is homolo-
gous to the mammalian mannose receptor (CD206), than 
 MRC1loMHCIIhi cells, suggesting that  MRC1hiMHCIIlo 
cells may act as M2-like macrophages in chickens. 
Functional studies of  MRC1hiMHCIIlo cells as M2 mac-
rophages should be conducted to refine the M1/M2 mac-
rophage dichotomy in chickens.
Compared to  MRC1hiMHCIIlo cells,  MRC1loMHCIIhi 
cells showed a high capability of expressing pro-
inflammatory cytokines (IL-1β, IL-6, and IL-12) dur-
ing LPS-induced inflammation in the present study, 
suggesting that  MRC1loMHCIIhi cells are more likely 
to show cytokine expression than  MRC1hiMHCIIlo 
cells.  MRC1hiMHCIIlo cells show a low level of 
Figure 7 Splenic MRC1loMHCIIhi cells were the main source of inflammatory cytokines. The mRNA expression of A IL‑1β, B IL‑6, C IL‑12, and 
D iNOS in FACS‑sorted  MRC1loMHCIIhi and  MRC1hiMHCIIlo cells from the spleen of chickens at 2 and 4 h post‑LPS injection. Data are normalized 
according to the data of the PBS group (n = 10). Data are represented as the mean values ± SD. **P < 0.01, ***P < 0.001.
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pro-inflammatory cytokine expression, which appears 
to be closely related to their phagocytic activity (Fig-
ure 2B), as the uptake of apoptotic bodies repressed the 
production of inflammatory mediators [53]. Indeed, red 
pulp macrophages with phagocytic activity against apop-
totic cells in mice showed low IL-1β mRNA expression 
[54]. Therefore,  MRC1loMHCIIhi cells clearly expressed 
cytokines, whereas the uptake of apoptotic cells was 
greater in  MRC1hiMHCIIlo cells than in  MRC1hiMHCIIlo 
cells. However, since the expression of cytokines and 
other inflammatory mediators were evaluated only 
at the genetic level in the present study, the expres-
sion of cytokines and other inflammatory mediators 
should also be examined at the protein level to improve 
understanding.
The adoptive cell transfer technique has been widely 
used to demonstrate the origin [38, 55] and function 
[56, 57] of mononuclear phagocytes in mouse studies, 
whereas very few studies have been conducted in chick-
ens. To the best of our knowledge, this is the first study 
in chickens demonstrating the replenishment of tissue 
resident macrophages in conjunction with the monocytic 
infiltration of PBMCs. Adoptive transfer of CTV-labelled 
PBMCs via the intravenous route in chickens demon-
strated that the observed  MRC1hiMHCIIlo cells were 
newly infiltrated into spleen, in which their phenotype 
switched to that of  MRC1loMHCIIhi cells at later time 
Figure 8 Splenic MRC1hiMHCIIlo cells showed a superior bacterial killing capacity compared to that of MRC1loMHCIIhi cells when 
treated with LPS. A The bar graph represents the remaining bacteria in the FACS‑sorted  MRC1loMHCIIhi and  MRC1hiMHCIIlo cell lysates after 10 
(uptake assay) or 60 min (clearance assay) of gentamicin treatment. B The bar graph represents the bacterial killing capacity of  MRC1loMHCIIhi and 
 MRC1hiMHCIIlo cells. Data were calculated by subtracting the number of bacteria remaining after clearance from the number from the uptake assay 
(n = 10). Data are represented as the mean values ± SD. **P < 0.01.
Table 2 Phenotypic and functional characteristics of splenic MRC1loMHCIIhi and MRC1hiMHCIIlo monocyte/macrophage 
lineage cells during steady state and inflammatory conditions 
The last four lines represent the characteristics of splenic  MRC1loMHCIIhi and  MRC1hiMHCIIlo cells during LPS-induced inflammation.
 Characteristics MRC1loMHCIIhi MRC1hiMHCIIlo
Phenotype High MHCII, MHCI, CD80 High MRC1




Phenotype change Decreased MRC1 Increased granularity
Decreased MHCII
Cytokines ↑↑ ↑
Bactericidal activity ↑ ↑↑
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points. Unlike mammalian tissue resident macrophages, 
which are commonly self-maintained with a reduced 
monocyte contribution [47], the present data suggest that 
splenic monocytes/macrophages could be replenished by 
monocyte infiltration in chickens. However, the absolute 
number of  MRC1loMHCIIhi cells was also decreased at 
4 h post-LPS administration, suggesting the possibility of 
the migration of  MRC1loMHCIIhi cells into the inflam-
matory site (i.e., peritoneal cavity). Therefore, further 
study on the migration of splenic  MRC1+ cells to other 
sites, such as the peritoneum, could demonstrate where 
and how  MRC1+ cells react to inflammatory stimuli.
Similar to that observed in mammalian spleen, two 
kinds of macrophages (red pulp macrophages and 
ellipsoid-associated macrophages) are observed in 
chicken spleen [11]. However, the exact location of 
 MRC1loMHCIIhi and  MRC1hiMHCIIlo cells in the spleen 
is yet to be determined. Therefore, in future studies, 
immunohistochemical or live imaging approaches should 
be used to demonstrate the location and timing of the 
phenotypic changes, if any, in the two subsets.
MHCII, which is mainly expressed on antigen present-
ing cells, is considered an activation marker together 
with the costimulatory molecules (CD86 and CD80) in 
DCs and macrophages. For example, when bone marrow-
derived immature DCs and M0 macrophages are treated 
with LPS or IFN-γ, the surface expression of MHCII and 
costimulatory molecules is elevated, and immature cells 
are differentiated into activated mature DCs and M1 
macrophages, respectively [40]. Furthermore, treatment 
with several TLR ligands also induced the upregula-
tion of MHCII expression along with an increase in the 
expression of co-stimulatory molecules in chicken mac-
rophage cell lines [41]. However, in the present study, 
in contrast to the expectation that LPS injection would 
induce the elevation of MHCII expression, LPS-induced 
inflammation caused a decrease in MHCII expression on 
 MRC1hiMHCIIlo cells. Interestingly, however, no signifi-
cant difference was observed in  MRC1loMHCIIhi cells.
It is well known in mammals that the transcription 
of MHCII is tightly regulated by the master coactiva-
tor class II MHC transactivator (CIITA) [58]. The exact 
mechanism of MHCII downregulation during LPS-
induced inflammation was not elucidated in the current 
study, although the factors known to regulate MHCII 
expression were measured in spleen treated with LPS 
administered i.p. It has been reported that in mammals, 
COX-2, which is increased under inflammatory condi-
tions, can reduce MHCII expression by regulating CIITA 
via prostaglandin-dependent cAMP production [59]. In 
the present study, COX-2 showed a remarkable eleva-
tion in transcription in spleen that was treated with LPS 
i.p., suggesting that COX-2 may be a potential MHCII 
regulator during LPS-induced inflammation. Given that 
COX-2 can be produced in almost all types of immune 
cells during inflammatory conditions [60], the exact 
source and location of COX-2 production were not deter-
mined in the present study. Thus, it is hard to determine 
why  MRC1hiMHCIIlo cells were more affected by the 
increase in COX-2 in the spleen than  MRC1loMHCIIhi 
cells.
In conclusion, the current study demonstrated that 
chicken splenocytes contain phenotypically and func-
tionally distinct subsets of monocyte/macrophage line-
age cells. Moreover,  MRC1loMHCIIhi cells displayed a 
tendency to express inflammatory cytokines, whereas 
 MRC1hiMHCIIlo cells showed elevated mannose receptor 
expression and phagocytosis activity, implying that the 
two subsets might play distinct roles during infection (for 
instance, in antigen presentation and pathogen clearance, 
respectively). Further studies are necessary to elucidate 
the precise role of the subsets in protective immunity 
against extracellular and intracellular pathogens. Col-
lectively, the results of the present study provide insight 
to improve the understanding of the splenic monocyte/
macrophage lineage cells of the avian immune system.
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 Additional file 1. Flow cytometry gating strategy and isotype 
controls used for MRC1+ cells. A Gating strategy used for  MRC1loMHCIIhi 
and  MRC1hiMHCIIlo cells. Single cells were gated based on size and granu‑
larity using FSC‑A and SSC‑A and then sub‑gated using 7‑AAD to define 
the live cells. Then, the live cells were discriminated by the expression 
of MRC1‑PE (clone: KUL01), and then the  MRC1loMHCIIhi (solid line) and 
 MRC1hiMHCIIlo (broken line) cells were defined based on the expression of 
MRC1 and MHCII. B The background level of fluorescence was examined 
using the proper isotype controls. 
Additional file 2. General features of splenic MRC1+ cells. A Propor‑
tion and B absolute number of splenic mononuclear phagocytes from 
1‑ to 3‑week‑old chickens (n = 10). Data are represented as the mean val‑
ues ± SD. ***P <0.01. 
Additional file 3. Gating strategy used for the dead cell and OVA 
uptake assays. A Splenocytes from 3‑week‑old chickens were labelled 
with CTV for 10 min and boiled at 56 °C for 30 min to inactivate the cells. 
Dead cells were co‑incubated with bead‑sorted splenic  MRC1+ cells at a 
1:1 ratio for 1 h. Then, dead cell uptake was determined according to the 
 CTV+ cells among the  MRC1loMHCIIhi and  MRC1hiMHCIIlo cells using flow 
cytometry. B OVA uptake was determined by analysing intensity of FITC 
in  MRC1loMHCIIhi and  MRC1hiMHCIIlo cells. Then, the uptake ability was 
calculated from the data obtained at 39 °C, which was normalized accord‑
ing to data obtained at 4 °C. The histogram presents the intensity of FITC 
in each subset. 
Additional file 4. Influence of i.p. injection of LPS into chickens. 
Percentage and absolute number of splenic leukocytes after 4 h of 
treatment with PBS or LPS (n = 10). Data are represented as the 
mean values ± SD. 
Additional file 5. Genotyping of White Leghorn chickens based on 
LEI0258 and BF2 exon 2. The gDNA was extracted from blood samples 
of four randomly selected White Leghorn Chickens at the University 
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Animal Farm. LEI0258‑ and BF2‑targeting PCRs were performed. Addition‑
ally, BF2 SBT was performed by sequencing the BF2 exon 2 region from 
each of the four chickens. PCR amplification of the MHC‑B haplotypes 
using A LEI0258 microsatellites and B BF2 exon 2. C Nucleotide sequence 
alignment for BF2 exon 2 sequence‑based typing. M; DNA marker 
(100 bp), S1‑4; gDNA samples from each of the 4 chickens. 
Additional file 6. Blood MRC1+ monocytes showed the homogenous 
expression of MRC1 and MHCII. Blood was collected and diluted in PBS 
at a 1:1 ratio. PBMCs, which were isolated from diluted blood by using 
Ficoll‑Paque, were stained with anti‑MRC1 and MHCII antibodies and 
analysed by using flow cytometry. Representative dot plot of  MRC1+ 
monocytes from the PBMCs of chickens administered PBS or LPS. 
Additional file 7. Schematic diagram of the gentamicin protection 
assay.  MRC1loMHCIIhi (filled) and  MRC1hiMHCIIlo (open) cells were sorted 
by a FACS Aria II and coincubated with E. coli K99 for 1 h. After co‑incuba‑
tion, gentamicin (200 μg/mL) was used to kill the extracellular bacteria 
for 10 min (uptake assay) or 60 min (clearance assay). Cell lysates were 
incubated overnight on TSA agar to measure the CFU value.
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